Is SVB Leerink Becoming an EB?
I've noticed how SVB Leerink has been on a tear with healthcare and their newly-formed tech team in the past few months. They recently advised Dicerna on their $3.3b sale to Novo Nordisk on the healthcare side. On the tech side, they announced this morning that they are advising on the $5.4b sale of Quest Software to Clearlake Capital. The tech team has also recently expanded into LevFin and ECM, having just poached more MDs from Jefferies, Barclays, and the Global Head of Internet TMT at Goldman Sachs. This is all despite the fact that the tech team was launched this past September.
This makes me wonder if SVB Leerink is now, or possibly in the future, considered an Elite Boutique in the tech and/or healthcare sectors?
unlike EBs, SVB has a true, significant commercial banking operation. It's a beast that is hard to peg, much like JEF.
very true and very significant
But it got pegged by rates eh
this aged well.
Bump
EB is such a nebulous term. The question really is, is SVB becoming a top-tier investment bank? If they keep paying up for high quality MDs from other banks the answer is yes, the best partners are basically comp mercenaries. BBs seem to be a great place to build a list of clients, then you go to an EB to monetize it. It only really helps juniors if the buyside recognizes SVB is good though which will take time, so probably a place to keep in mind over the next several years.
I don’t think two deals qualifies a firm as an EB. They are alright but have historically mostly worked on financing stuff. That being said, they are expanding but are definitely not even close to the top boutiques yet
Okay Mr.MBA
Does anyone know the perks they offer?
Bump. Specifically do they pay for gym membership/cellphone bill? Also what’s there dinner expense policy?
Just saw another thread say that it was $30 for dinner, pay for phone bill and, $100 a year for gym - (the person who said this wasn't sure of the value of the gym membership though) - Also you can put 10% of your salary in SVB stock at a 15% discount to market price
Just looked through all of their m&a transactions this year and they have fewer than 15 total transactions with only 2-3 being over a billion in value. Definitely not comparable to top independent advisory firms
no
The term "EB" does not (or should not) apply to single coverage groups that are really good. I don't know anything about SVB but judging by your post they have 2 coverage groups? HC and TMT? Do they have offices in both NYC and SF? What about a media group in LA? Energy team in HOU? Industrials, Real Estate, Consumer? Are they international?
The term EB becomes useless if you use it to include every bank that is 1 elite coverage group, like Qatalyst for example. I think this forum needs a different name for these? Maybe regional EB. Because there is clearly a difference between those banks and standard EBs like PJT/EVR/LAZ/PWP and so on.
Aside from their HQ in Boston, they have a big NY & SF office, they also have an office in Charlotte and just launched a new office in Nashville.
The office in Charlotte is tiny. They have like 1/5th of that floor, unless they've changed offices since late 2019.
Seems like it needs a bit more of a track record than that and a niche vertical expertise or two. I assume it is the lead advisor on these large transactions?
Believe the $3.3B deal, Centerview was lead.
No, Centerview was lead advisor on the Dicerna one.
This is a perfect example of misinformation among younger bankers. If you are co-advising the large deals, that doesn't demonstrate that you are on par with BBs and EB. This frequently gets brought up with Triple Tree as well.
There's nothing wrong getting tombstones and building a brand through co-advising, but prospects know what role co-advisors play and its an uphill battle to demonstrate relevance when you are going up against top IBs.
Leerink is elite when it comes to middle-market/lower-middle-market ECM. They are consistently in the top 3 with Jefferies and Cowen predominantly in healthcare; it's basically a triopoly. From an advisory/M&A perspective, they are decidedly not in the same tier as EBs.
Lmao a triopoly in LMM ECM. That's so specific/niche, it's like saying my little tech startup is elite because it absolutely dominates at providing dog walking services between $4.6-4.75/hour in the suburbs of Atlanta during Friday afternoons. Literally only two other tech startups are able to compete with mine in that arena.
LMM ECM healthcare*
They're not in the top 50 for US M&A YTD according to FactSet. Not sure if they just missed them but still not a big player in M&A (realize they have other products but an EB should have a decent M&A platform).
Are you looking at just healthcare or the entire spectrum? not surprised that there are 50 other banks that outdo leerink across 10 coverage groups and 3 product groups compared to just leerink's HC team + a month of having some tech guys lol
Entire spectrum, not just one coverage group
The OP literally asked if it was becoming an EB. Would deal volume and multiple verticals not be responsive to that?
We get it bro, you interned at an "EB".
To all the people giving MS, would love to hear why and if you have a better source rather than just getting angry (guessing all y'all are Leerink employees or hopefuls?). I'm just stating something factual from the league table with the longest list of banks I could find. Also, I didn't intern at an EB, I work in PE (and was at a BB before that). Source for league table: https://www.factset.com/hubfs/mergerstat_em/monthly/US-Flashwire-Monthl…
First, it’s a bank with 1 or 2 industry groups, so obviously they won’t be relevant on league tables which spread across industries.
Second, league tables are always a joke if they give full credit to co-advisors, which they usually do.
No it isn’t becoming an EB - it will be an EB when it shows up on top ten league tables
Evercore and Lazard are the only EBs in the top 10 for m&a currently. are the rest now EBs?
If LionTree and Qatalyst aren't EBs, SVBL definitely isn't. As others have said, to become an EB a bank needs to evolve beyond a single industry vertical.
LionTree and Qatalyst are EBs...
I don't think they are an EB, but they certainly pay like a EB, especially the tech team. Business Insider wrote how in order to lure talent, "SVB is also kicking in more to the bonus pool than traditional banks, with no limit on total compensation… and uncapped bonus pool." I'm not sure if this necessarily applies to the juniors they're hiring, but if so I wouldn't be surprised if come bonus season their analyst's total comp is on the high end when compared to EBs.
https://www.businessinsider.com/svb-leerink-hiring-investment-banking-c…
delete
Looking at league tables right now is dumb. The HC services and TMT teams came together over last 6-12 months. Will take almost 2-3 years before you start seeing deals.
they are modeled more after Jefferies (with financing, research and ECM arms) vs Centerview / Perella, etc. They should do well but don’t expect them to just headline grabbing M&A and nothing else. Will be a volume driven, diversified platform with deal size and products across the spectrum. They’ve paid people very well (including junior / mid level) to hire away.
I wonder what the exits are gonna look like for those on the tech team.
Unemployment benefits is my guess
Let’s have this discussion when they are in top 10 league tables.
"Top 10 league table" argument is pretty weak for EB, Leerinks bread and butter as of right now is biopharma. There is basically no M&A activity in the space, this has been a known problem for around the last 14 months. Licensing deals or asset acquisitions I don't believe show up on dealogic league tables which is much more common in the space. We will see how their new HC services and Tech team plays out for them. Agree with some of the above posters, seems more like a Jefferies.
Wonder if they'll make the Top 10 this year?
ha
Their corporate bank and private bank are elite. Makes sense that they would add IB services to the mix. However, their expertise (enterprise wide) is in the healthcare / tech lane. I would compare that to a niche consulting firm that's best in class in a vertical (like A&M, FTI, Alix in Restructuring / Turnaround). Not sure they do much outside of that lane. But within it, yikes!
I think they have the potential to be an EB. Especially if single coverage group firms such as LionTree and Qatalyst are already considered to be EBs.
They already did the Clearlake’s $5.4B deal to get Quest. That’s already bigger than any MM
Sheesh did not see that
I'm fucking dying
delet this OP
Goes to show that an investment bank is much more than just its M&A advisory arm.
Um, I don't think investment banking is the issue here. If SVB was just an advisory and capital markets arm, it would still be alive.
I think that was his point.
That’s what I’m saying. I bet most people here didn’t even know they did stuff outside of advisory. My point was, people hear “investment bank” and automatically assume that advisory, for a bank SVBs size, is all they do
Yes, SVB is an EB (Erased from history Boutique)
Extinct Boutique
Aged so badly in 24h it’s insane
The original post is from Dec 2021. Still wild though.
Odit non aliquid quisquam voluptates voluptatem ipsum. Porro qui veniam aspernatur qui et. Blanditiis et quos nobis vel ratione et. Odit at doloremque ut natus consequatur et. Voluptatem sunt enim dolorem repudiandae. Esse aut deleniti libero vero repudiandae nam. Culpa assumenda quasi iste cumque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Et eveniet ipsa laborum voluptas at. Nostrum occaecati rerum quas nostrum aut incidunt. Est eligendi sit molestiae minima blanditiis. Et dolores quasi quo nihil officia non. Ullam vel corporis occaecati in.
Quo labore sit quae dolorem iure molestiae illum. Et aperiam accusantium perferendis dignissimos exercitationem quos. Delectus ea possimus quam perspiciatis rerum nam eos aliquam. Quos voluptatum aspernatur ratione nobis nesciunt. Sed a amet quod sequi est corporis nemo.
Aperiam est inventore et. Temporibus omnis et consectetur error tempore dolore eum. Necessitatibus doloremque tempora eligendi atque quasi. Aliquam tempore maxime enim similique. Sed odio aut possimus.
Iure totam eos magnam natus rem. Et quisquam qui accusamus. Voluptatem quaerat consequuntur et nulla quaerat at minima. Dolor ducimus omnis nihil veritatis ipsa cumque. Consequatur est dolore velit vel. Iste rerum molestias vitae.
Ipsam rerum vero libero et consequatur. Et iure impedit vel repellendus excepturi. Totam ut enim incidunt consequatur esse consequatur. Minima aut delectus pariatur in eum aperiam aperiam iure.
Dignissimos consequatur aliquam iusto ex sint qui. Nemo voluptate voluptate nihil velit. Dolorem velit perspiciatis consequatur aut eius non occaecati. Facere dolorum sit et sit.
Incidunt deleniti delectus dignissimos eos atque in facere. Sed ullam quo modi fuga explicabo necessitatibus nesciunt impedit. Dolores harum eligendi aut ipsa doloribus. Beatae explicabo repellendus odit vel.
Et distinctio illum suscipit ratione sapiente facere. Provident sed deleniti consequatur minus omnis et sunt ab. Dolorem ut totam saepe fugit distinctio illo nihil. Rerum blanditiis error nostrum et qui dolor.
Enim alias ullam vitae. Facere illum vitae ut nihil et architecto non quod.